PENTA 5

28

Dec, 2011

Age and CD4 Count at Initiation of Antiretroviral Therapy in HIV-InfectedChildren: Effects on Long-term T-Cell Reconstitution.

 

Authors:  Lewis J, Walker AS, Castro H, De Rossi A, Gibb DM, Giaquinto C, Klein N, Callard R.

Published in: J Infect Dis. 2011 Dec 28.

Read

18

Apr, 2007

3TC+ABC maintains virological superiority over ZDV+3TC and ZDV+ABC beyond 5 years in children: the PENTA 5 trial.

 

Authors:  Gibb DM, Green H, Saidi Y, Pillay D, Compagnucci A, Harper L, Walker AS, Castelli-Gattinara G, Della Negra M, Levy J, Candeias F, Butler K, Feiterna-Sperling C, Wintergerst U, Giaquinto C on behalf of PENTA 5.

Published in: AIDS 2007; 21:947-955

Read

18

Apr, 2005

Relationship between changes in thymic emigrants and cell-associated HIV-1 DNA in HIV-1 infected children initiating antiretroviral therapy.

 

Authors: De Rossi A, Walker AS, De Forni D, Klein N, Dibb DM for PENTA.

Published in: Antivir Ther. 2005;10(1):63-71

Read

18

Apr, 2004

Maintaining the nelfinavir trough concentration above 0.8 mg/L significantly improves virological response in HIV-1-infected children

 

Authors: Burger DM, Bergshoeff A, de Groot R, Gibb DM, Walker AS, Tréluyer JM, Hoetelmans R, on behalf of the PENTA 5 study group.

Published in: J Paediatr 2004; 145(3): 403-405.

Read

18

Apr, 2004

Effect of concurrent zidovudine use on the resistance pathway selected by abacavir-containing regimens

 

Author: Lanier ER, Givens N, Stone C, Griffin P, Gibb DM, Walker AS, Tisdale M, Irlbeck D, Underwood M, St Clair M and Ait-Khaled M

Published in: HIV Medicine 2004; 5: 394-399.

Read

18

Apr, 2003

Three year follow-up of the PENTA 5 trial.

 

Authors: Gibb DM, Giaquinto C, Walker AS, Harper L, Compagnucci A, Saidi Y, Moulinier C, Aboulker JP, Babiker AG, Debré M, Darbyshire JH on behalf of the PENTA 5 Executive Committee

Published: 10th Conference on Retroviruses and Opportunistic Infections February 10th – 14th, 2003 – Boston. Poster G1-12

Read

18

Apr, 2003

Relationship between Cell-Associated HIV-1 DNA and Thymic Output in HIV-1 infected Children Initiating Antiretroviral Therapy in the PENTA 5 Trial

 

Authors: De Rossi A, Walker AS, De Forni D, Gibb DM on behalf of PENTA.

Published in: 10th Conference on Retroviruses and Opportunistic Infections February 10th – 14th, 2003 – Boston. Poster P-17

Read

18

Apr, 2003

Adherence to Prescribed Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Children in the PENTA 5 Trial.

 

Author: Gibb DM, Goodall RL, Giacomet V, McGee L, Compagnucci A, Lyall H for PENTA.

Published in: Pediatr Inf Dis J 2003; 22 (1): 56-62

Read

18

Sep, 2002

Zidovudine (ZDV) appears to prevent selection of K65R and L74V, mutations normally selected by Abacavir (ABC) mono- or combination therapies not containing ZDV.

 

Authors: Ait-Khaled M, Lanier R, Richards N, Stone C, Griffin P, Gibb DM, Walker AS, Craig C, Loeliger E, Tisdale M

Published in: 2002 International Meeting of the Institute of Human Virology, September 9-13, 2002, Baltimore

18

Jul, 2002

Adherence to HAART in children: results from a questionnaire study of children in PENTA 5 trial.

 

Authors: Giacomet V, Gibb DM, Goodall R, McGee L, Walker AS, Giaquinto C.

Published in: XIV World AIDS Conference, Barcelona, Spain, 7-12 July 2002. Poster TuPpB2050)

Read